儿童急非淋白血病治疗相关并发症:预防及处理
The treatment outcome of pediatricacute myeloid leukemia(AML)has progressively improved in many developed countries,with the event-free survival(EFS)and overall survival(OS)nowaround55％and65％.However the treatment result is still unsatisfactory in many developing countries.The improvement of outcome is due to increased intensity of chemotherapyand enhancement of supportive care.The intensive chemotherapy isassociated with more complicationsand treatment-related mortality.
儿童患者 急性非淋巴细胞白血病 临床治疗 并发症 疾病预防
李志光
香港中文大学威尔斯亲王医院儿童癌症中心
国内会议
广州
中文
6-14
2014-05-22（万方平台首次上网日期，不代表论文的发表时间）